Molecular Vision: Vincent, Mol Vis 2009; 15:1700-1708. Table 2

Table 2. Individual patient demographics and examination findings.

Patient ID	Sex	Affected status	Age at last exam	Age at onset	Age at offset	Visual acuity		Pachymetry		Anesthesiometry
						RE	LE	RE	LE
I-1	F	Unaffected	65	N/A	N/A	6/6	6/15-1	568	569	ND
I-2	M	Affected	64	‘childhood’	unsure	6/7.5-1	6/7.5-	poor	reading	0.76
II-2	M	Affected	41	10 years	21	6/12	6/7.5	559	558	0.82
II-3	M	Affected	39	6 years	13	6/6+	6/6	550	552	0.38
II-5	M	Affected	38	5 years	22	6/6	6/6+1	513	491	0.78
II-7	M	Unaffected	37	N/A	N/A	6/6	6/5	554	549	0.42
III-1	F	Unaffected	15	N/A	N/A	6/9	6/6	566	558	0.29
III-2	F	Affected	14	5 years	ongoing	6/5	6/5	542	540	0.41
III-3	F	Affected	12	5 years	ongoing	6/5	6/5-1	558	549	0.26
III-4	F	Unaffected	11	N/A	N/A	6/5-	6/7.5-	ND	ND	0.28
III-5	M	Unknown	5	Nil to date	N/A	6/6	6/7.5-	ND	ND	ND
III-6	M	Unknown	4	Nil to date	N/A	6/6	6/6	ND	ND	ND
III-7	F	Unknown	10	Nil to date	N/A	6/5-2	6/6+	ND	ND	ND
III-8	M	Unknown	5	Nil to date	N/A	6/6-2	6/6-	ND	ND	ND

Table 2 lists the demographic features for each individual in the pedigree including sex (F = female, M = male), age at last examination in years, affectation status, and age in years at onset and offset of the recurrent corneal erosions for those affected. For those unaffected this information is not applicable (N/A). Clinical examination findings listed include visual acuity measured with the Snellen chart, pachymetry indicating central corneal thickness measured in microns, and anaesthesiometry, units are in millibars. When the information was not available, it is listed in the table as Not Done (ND).